Mersana Therapeutics (MRSN)
Q2 2018 Results Earnings Conference Call
August 15, 2018 08:00 PM ET
Executives
Eva Jack - Chief Business Officer
Anna Protopapas - CEO
Tim Lowinger - Chief Scientific Officer
Dave Spellman - CFO
Analysts
Jonathan Chang - Leerink Partners
Jessica Fye - JP Morgan
Debjit Chattopadhyay - H.C. Wainwright
Boris Peaker - Cowen
Presentation
Operator
Good morning and welcome to the Mersana Therapeutics’ Second Quarter 2018 Financial Results Conference Call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call.
I would